Serum lactate dehydrogenase (LDH) as a prognostic index for non-Hodgkin's lymphoma
- 1 October 1982
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 18 (10) , 945-949
- https://doi.org/10.1016/0277-5379(82)90242-5
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Lactic dehydrogenase in the monitoring and prognosis of testicular cancerCancer, 1981
- Prognostic significance of serum lactate dehydrogenase in malignant lymphomaCancer, 1980
- Serum lactic dehydrogenase as a prognostic tool for non-Hodgkin lymphomasBlood, 1979
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphomaCancer, 1976
- Pretreatment Serum Lactate Dehydrogenase Predicting Metastatic Spread in Ewing's SarcomaAnnals of Internal Medicine, 1975
- Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPPCancer, 1975
- American Burkitt's lymphoma: A clinicopathologic study of 30 casesThe American Journal of Medicine, 1975
- A decade of combination chemotherapy of advanced Hodgkin's diseaseCancer, 1972
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958